http://www.curetoday.com/cure-tv/dana-farber-leads-kadcyla-atempt-study-in-her2-positive-breast-cancer
Dana-Farber Leads Kadcyla ATEMPT Study in HER2-Positive Breast Cancer




Experts review an innovative study, called the ATEMPT study, which looks at adjuvant T-DM1 in women with HER2-positive breast cancer.
Print | cure Printing...